CD274 and cancer: found that tumor cells with epithelial-mesenchymal transition and MMP-11+ cancer-associated fibroblasts are more sensitive to NHIPEC, and NHIPEC can improve the immunosuppressive tumor microenvironment, enhancing the anti-tumor effect of PD-L1 antibodies in HGSOC.